Collegium Pharmaceutical, Inc.'s CEO to Present at the Jefferies and Co. 2013 Global Health Care Conference in New York on June 4, 2013
5/31/2013 6:40:06 AM
More...
|
Collegium Pharmaceutical, Inc.'s CEO to Present at the UBS Global Health Care Conference in New York on May 20, 2013
5/17/2013 7:01:50 AM
More...
|
Collegium Pharmaceutical, Inc. Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society's 32nd Annual Scientific Meeting
5/8/2013 10:36:42 AM
More...
|
Collegium Pharmaceutical, Inc. Announces Successful Completion of Clinical Study Evaluating the Impact of Tampering on Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
4/17/2013 9:27:20 AM
More...
|
Collegium Pharmaceutical, Inc. Names Douglas Carlson to Vice President of Business Development
4/3/2013 6:15:06 AM
More...
|
Collegium Pharmaceutical, Inc.'s CEO to Present at the Cowen and Company 33rd Annual Health Care Conference in Boston on March 6, 2013
2/28/2013 6:52:29 AM
More...
|
Collegium Pharmaceutical, Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid Product
2/12/2013 9:00:17 AM
More...
|
Collegium Pharmaceutical, Inc. Announces Relocation to Massachusetts
1/17/2013 9:33:01 AM
More...
|
Collegium Pharmaceutical, Inc. to Present at Piper Jaffray's 24th Annual Healthcare Conference
11/27/2012 9:37:14 AM
More...
|
Collegium Pharmaceutical, Inc. Announces Poster Presentation for Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid at 2012 American Association of Pharmaceutical Scientists Annual Meeting
10/19/2012 9:25:58 AM
More...
|
|